Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4096201
Max Phase: Preclinical
Molecular Formula: C30H38N5NaO10S
Molecular Weight: 661.73
Molecule Type: Small molecule
Associated Items:
ID: ALA4096201
Max Phase: Preclinical
Molecular Formula: C30H38N5NaO10S
Molecular Weight: 661.73
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCS(=O)(=O)NC[C@@H](O)[C@@H](O)[C@@H]1O[C@@](OCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)(C(=O)[O-])C[C@H](O)[C@H]1NC(C)=O.[Na+]
Standard InChI: InChI=1S/C30H39N5O10S.Na/c1-3-46(42,43)31-17-25(38)27(39)28-26(32-19(2)36)24(37)16-30(45-28,29(40)41)44-15-7-14-35-18-23(33-34-35)22-12-10-21(11-13-22)20-8-5-4-6-9-20;/h4-6,8-13,18,24-28,31,37-39H,3,7,14-17H2,1-2H3,(H,32,36)(H,40,41);/q;+1/p-1/t24-,25+,26+,27+,28+,30+;/m0./s1
Standard InChI Key: OSTMNYNAJLDBOS-ZEOHCEFUSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 661.73 | Molecular Weight (Monoisotopic): 661.2418 | AlogP: 0.12 | #Rotatable Bonds: 15 |
Polar Surface Area: 222.43 | Molecular Species: ACID | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.86 | CX Basic pKa: | CX LogP: 0.38 | CX LogD: -3.11 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.12 | Np Likeness Score: -0.42 |
1. Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R.. (2017) Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion., 60 (3): [PMID:28103033] [10.1021/acs.jmedchem.6b01111] |
Source(1):